Change of CD4+ CD25+ regulatory T cells in asthmatic rat and the effect of dexamethasone on CD4+ CD25+T cells
Yiqiang Chen, Hong-Xia Wen, Xiaoying Zou, Jing-nin Deng, Huan‐Zhong Shi
Abstract
Yiqiang Chen, Hong-Xia Wen, Xiaoying Zou, Jing-nin Deng, Huan‐Zhong Shi
Abstract
Objective To investigate the change of CD4+ CD25+ T cells in bronchoalvelar lavage fluid (BALF), blood and spleen of asthmatic rat and the effect of dexamethasone on CD4 + CD25 + T cells.Methods Fifty SD rats were randomly divided into five groups with 10 rats in each group:control group (A), asthmatic group (B), dexamethasone low-dose group (C), dexamethasone mid-dose group (D),dexamethasone high-dose group (E). Group A was established by saline. The rat was injected saline 1 ml in 1 day and challenged from days 15 to 21 by saline 10 ml. The group B,C,D,E,were sensitized on days 1 by injected OVA 1mg and 1 % OVA aerosol challenged from days 15 to 21. The group C, D, E were injected dexamethasone(0. 2 mg/kg, 1 mg/kg,2 mg/kg) after challenges 30 minutes. CD4+ CD25+ T cells in BALF,blood and spleen are measured by flow cytometric analysis. Results BALF, blood and spleen's ratio of CD4+ CD25+ T cells to CD4+ T cells of group B were significantly higher than those in group A [(42.21±5.62)% vs (18.76±5.85)%, P <0. 01],[(12. 69±2.70)% vs (6.27±1.73)%, P<0.01],[(11. 15± 1.05)% vs (7. 85±2.13)%, P <0.05]. In BALF, group C(10.49±4.03)%,group D (13.28±5.12)%, group E (7.51 ± 5.3)%, compared with group A (18.76 ±5.85)% group B (42.21± 5.62) %, the differences were significant ( all P < 0. 05 ). In blood, group C ( 6.03 ± 1.43 ) %,group D(4. 88±0.95)%, compared with group A(6.21 ± 1.73)%, the differences were no significant.Group E( 3.49 ± 0.62 ) %, compared with group A ( 6.21 ± 1.73 ) %, group C ( 6.03 ± 1.43 ) %, the differences were significant, (allP <0.05). In spleen,group C (7. 25±1.82) % ,group D(8. 63±3.18) %,compared with group A (7.85 ± 2. 13) %, the differences were no significant. Group E ( 3.38 ± 1.37 ) %compared with group A ( 7.85 ± 2.13 ) %, group C ( 7.25 ± 1.82 ) %, group D ( 8. 63 ± 3.18 ) %, the differences were significant, ( P <0.05). Conclusions The ratio of CD4+ CD25+ T cells to CD4+ T cells of asthmatic rat exit predominance expression, which may be one of mechanisms of asthma pathogenesis.Dexamethasone can depress CD4+ CD25+ T cells predominance expression. The changes of CD4+ CD25+ T cells in BALF is consistent with that in the blood and spleen,which suggested that monitoring the changes of CD4+ CD25+ T cells in blood and spleen can be useful to understand the situatioan of BALF. Key words: Asthma; CD4+CD25+T cells; Dexametasone
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the change of CD4+ CD25+ T cells in bronchoalvelar lavage fluid (BALF), blood and spleen of asthmatic rat and the effect of dexamethasone on CD4 + CD25 + T cells.Methods Fifty SD rats were randomly divided into five groups with 10 rats in each group:control group (A), asthmatic group (B), dexamethasone low-dose group (C), dexamethasone mid-dose group (D),dexamethasone high-dose group (E). Group A was established by saline. The rat was injected saline 1 ml in 1 day and challenged from days 15 to 21 by saline 10 ml. The group B,C,D,E,were sensitized on days 1 by injected OVA 1mg and 1 % OVA aerosol challenged from days 15 to 21. The group C, D, E were injected dexamethasone(0. 2 mg/kg, 1 mg/kg,2 mg/kg) after challenges 30 minutes. CD4+ CD25+ T cells in BALF,blood and spleen are measured by flow cytometric analysis. Results BALF, blood and spleen's ratio of CD4+ CD25+ T cells to CD4+ T cells of group B were significantly higher than those in group A [(42.21±5.62)% vs (18.76±5.85)%, P <0. 01],[(12. 69±2.70)% vs (6.27±1.73)%, P<0.01],[(11. 15± 1.05)% vs (7. 85±2.13)%, P <0.05]. In BALF, group C(10.49±4.03)%,group D (13.28±5.12)%, group E (7.51 ± 5.3)%, compared with group A (18.76 ±5.85)% group B (42.21± 5.62) %, the differences were significant ( all P < 0. 05 ). In blood, group C ( 6.03 ± 1.43 ) %,group D(4. 88±0.95)%, compared with group A(6.21 ± 1.73)%, the differences were no significant.Group E( 3.49 ± 0.62 ) %, compared with group A ( 6.21 ± 1.73 ) %, group C ( 6.03 ± 1.43 ) %, the differences were significant, (allP <0.05). In spleen,group C (7. 25±1.82) % ,group D(8. 63±3.18) %,compared with group A (7.85 ± 2. 13) %, the differences were no significant. Group E ( 3.38 ± 1.37 ) %compared with group A ( 7.85 ± 2.13 ) %, group C ( 7.25 ± 1.82 ) %, group D ( 8. 63 ± 3.18 ) %, the differences were significant, ( P <0.05). Conclusions The ratio of CD4+ CD25+ T cells to CD4+ T cells of asthmatic rat exit predominance expression, which may be one of mechanisms of asthma pathogenesis.Dexamethasone can depress CD4+ CD25+ T cells predominance expression. The changes of CD4+ CD25+ T cells in BALF is consistent with that in the blood and spleen,which suggested that monitoring the changes of CD4+ CD25+ T cells in blood and spleen can be useful to understand the situatioan of BALF. Key words: Asthma; CD4+CD25+T cells; Dexametasone
Key concepts: Dexamethasone, Medicine, Spleen, Internal medicine, IL-2 receptor, Saline, Endocrinology, Immunology